Literature DB >> 16036804

Tumor necrosis factor alpha leads to increased cell surface expression of CXCR4 in SK-N-MC cells.

Kevin Rostasy1, Gullue Gorgun, Yelena Kleyner, Anthony Garcia, Michael Kramer, Suzanne M Melanson, Jean Marie Mathys, Constantin Yiannoutsos, Paul R Skolnik, Bradford A Navia.   

Abstract

Both host and viral factors play an important role in the pathogenesis of human immunodeficiency virus (HIV)-associated bran injury. In this study, the authors examined the interactions between tumor necrosis factor (TNF)-alpha, CXCR4, the alpha chemokine receptor, and three HIV isolates, including the T-tropic viruses, HIV-1(MN) and HIV-1(IIIB), and the dual tropic virus, HIV-1(89.6). The authors show by flow cytometry that treatment of differentiated SK-N-MC cells with TNF-alpha induces a significant increase in the cell surface expression of CXCR4 in a time- and dose-dependent manner. The effect is partly regulated at the level of transcription. To assess the biological significance of this finding, we show that TNF-alpha potentiates the ability of the above mentioned HIV isolates to induce neuronal apoptosis and that the effect is significantly reduced by pretreating cells with monoclonal antibodies to either CXCR4 and TNF-alpha. Together these results suggest that TNF-alpha may render neuronal cells vulnerable to the apoptotic effects of HIV by increasing the cell surface expression of CXCR4 and thus identify another mechanism by which TNF-alpha contributes to the pathogenesis of HIV-associated brain injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16036804     DOI: 10.1080/13550280590952763

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  56 in total

1.  Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines.

Authors:  S K Gupta; P G Lysko; K Pillarisetti; E Ohlstein; J M Stadel
Journal:  J Biol Chem       Date:  1998-02-13       Impact factor: 5.157

2.  Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center.

Authors:  I P Everall; R K Heaton; T D Marcotte; R J Ellis; J A McCutchan; J H Atkinson; I Grant; M Mallory; E Masliah
Journal:  Brain Pathol       Date:  1999-04       Impact factor: 6.508

3.  Tumor necrosis factor-alpha drives HIV-1 replication in U937 cell clones and upregulates CXCR4.

Authors:  P Biswas; B Mantelli; F Delfanti; M Cota; G Vallanti; M Mengozzi; E Vicenzi; A Lazzarin; G Poli
Journal:  Cytokine       Date:  2001-01-07       Impact factor: 3.861

4.  The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1.

Authors:  E Oberlin; A Amara; F Bachelerie; C Bessia; J L Virelizier; F Arenzana-Seisdedos; O Schwartz; J M Heard; I Clark-Lewis; D F Legler; M Loetscher; M Baggiolini; B Moser
Journal:  Nature       Date:  1996-08-29       Impact factor: 49.962

5.  Chemokine receptor expression and signaling in macaque and human fetal neurons and astrocytes: implications for the neuropathogenesis of AIDS.

Authors:  R S Klein; K C Williams; X Alvarez-Hernandez; S Westmoreland; T Force; A A Lackner; A D Luster
Journal:  J Immunol       Date:  1999-08-01       Impact factor: 5.422

6.  Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1.

Authors:  D Giulian; K Vaca; C A Noonan
Journal:  Science       Date:  1990-12-14       Impact factor: 47.728

7.  SDF-1alpha is expressed in astrocytes and neurons in the AIDS dementia complex: an in vivo and in vitro study.

Authors:  Kevin Rostasy; Christophe Egles; Ashok Chauhan; Michelle Kneissl; Padmanabhan Bahrani; Constantin Yiannoutsos; Dale D Hunter; Avindra Nath; John C Hedreen; Bradford A Navia
Journal:  J Neuropathol Exp Neurol       Date:  2003-06       Impact factor: 3.685

8.  Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia.

Authors:  S L Wesselingh; C Power; J D Glass; W R Tyor; J C McArthur; J M Farber; J W Griffin; D E Griffin
Journal:  Ann Neurol       Date:  1993-06       Impact factor: 10.422

9.  Clinical-neuropathologic correlation in HIV-associated dementia.

Authors:  J D Glass; S L Wesselingh; O A Selnes; J C McArthur
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

10.  HIV-1 Tat induces neuronal death via tumor necrosis factor-alpha and activation of non-N-methyl-D-aspartate receptors by a NFkappaB-independent mechanism.

Authors:  D R New; S B Maggirwar; L G Epstein; S Dewhurst; H A Gelbard
Journal:  J Biol Chem       Date:  1998-07-10       Impact factor: 5.157

View more
  6 in total

Review 1.  Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals.

Authors:  Uraina S Clark; Ronald A Cohen
Journal:  Curr Opin Investig Drugs       Date:  2010-08

Review 2.  Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology.

Authors:  Meizhang Li; Richard M Ransohoff
Journal:  Prog Neurobiol       Date:  2007-11-26       Impact factor: 11.685

3.  Tissue microenvironment modulates CXCR4 expression and tumor metastasis in neuroblastoma.

Authors:  Libo Zhang; Herman Yeger; Bikul Das; Meredith S Irwin; Sylvain Baruchel
Journal:  Neoplasia       Date:  2007-01       Impact factor: 5.715

Review 4.  The AIDS dementia complex: clinical and basic neuroscience with implications for novel molecular therapies.

Authors:  B A Navia; K Rostasy
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

Review 5.  Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors.

Authors:  Hyunsuk Shim; Shinya Oishi; Nobutaka Fujii
Journal:  Semin Cancer Biol       Date:  2008-11-25       Impact factor: 15.707

6.  Examination of structure-activity relationship of viologen-based dendrimers as CXCR4 antagonists and gene carriers.

Authors:  Jing Li; Ana-Maria Lepadatu; Yu Zhu; Marius Ciobanu; Yan Wang; Simona C Asaftei; David Oupický
Journal:  Bioconjug Chem       Date:  2014-05-12       Impact factor: 4.774

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.